Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Clayman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JAMA|December 11, 1981
Images and reflectionsC B Clayman
JAMA|June 17, 1974
Letter: Tolbutamide revisitedC B Clayman
JAMA|September 19, 1977
Evaluation of cimetidine (tagamet). An antagonist of hydrochloric acid secretionC B Clayman
JAMA|December 5, 1980
The carbonate affair: chalk one upC B Clayman
JAMA|May 23, 1980
Mass screening: is it cost-effective?C B Clayman
JAMA|January 27, 1989
Mass screening for colorectal cancer: are we ready?C B Clayman
JAMA|August 25, 1975
The prostaglandinsC B Clayman
JAMA|August 28, 1981
Malaria: are we prepared?C B Clayman, R D Powell
JAMA|October 28, 1983
Landmark perspective: Bertram W. Sippy and ulcer disease therapyG M Zucker, C B Clayman
JAMA|December 13, 1985
Lowered cost potential for hepatitis B vaccineR M Craig, C B Clayman
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA|December 11, 1981
Images and reflectionsC B Clayman
JAMA|June 17, 1974
Letter: Tolbutamide revisitedC B Clayman
JAMA|September 19, 1977
Evaluation of cimetidine (tagamet). An antagonist of hydrochloric acid secretionC B Clayman
JAMA|December 5, 1980
The carbonate affair: chalk one upC B Clayman
JAMA|May 23, 1980
Mass screening: is it cost-effective?C B Clayman
JAMA|January 27, 1989
Mass screening for colorectal cancer: are we ready?C B Clayman
JAMA|August 25, 1975
The prostaglandinsC B Clayman
JAMA|August 28, 1981
Malaria: are we prepared?C B Clayman, R D Powell
JAMA|October 28, 1983
Landmark perspective: Bertram W. Sippy and ulcer disease therapyG M Zucker, C B Clayman
JAMA|December 13, 1985
Lowered cost potential for hepatitis B vaccineR M Craig, C B Clayman
Pageof 2